ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer.

Sarah Halford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.